Gilead Sciences logo

Gilead Sciences

Crunchbase
Crunchbase

Deals on record

1

Common Fundraising Type

Series B

Tentarix Biotherapeutics is a biotechnology company that uses its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics.

Series B
$35M
09/06/2023
Article